
The government has urged the British public to take part in an antiviral drugs study designed to help the NHS treat coronavirus patients.
Volunteers will receive doses of molnupiravir, a drug that was approved by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) in early November. It was the first regulator to give it the green light.